An assessment of the potential toxicity of DPP-4 Inhibitors

被引:0
|
作者
Russell, Jason L. [1 ]
Casavant, Marcel J. [2 ]
Spiller, Henry A. [3 ]
Mercurio-Zappala, Maria [4 ]
Huffman, R. Michelle [3 ]
机构
[1] Ohio State Wexner Med Ctr, Columbus, OH USA
[2] Nationwide Childrens Hosp, Columbus, OH USA
[3] Cent Ohio Poison Ctr, Columbus, OH USA
[4] New York City Poison Control Ctr, New York, NY USA
关键词
Hypoglycemic; National Poison Data System; Adverse drug event;
D O I
暂无
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
182
引用
收藏
页码:657 / 657
页数:1
相关论文
共 50 条
  • [1] DPP-4 inhibitors
    Ahren, Bo
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 21 (04) : 517 - 533
  • [2] DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics
    Chayakrit Krittanawong
    Andrew Xanthopoulos
    Takeshi Kitai
    Natalia Branis
    HongJu Zhang
    Marrick Kukin
    Heart Failure Reviews, 2018, 23 : 355 - 361
  • [3] DPP-4 inhibitors and heart failure: a potential role for pharmacogenomics
    Krittanawong, Chayakrit
    Xanthopoulos, Andrew
    Kitai, Takeshi
    Branis, Natalia
    Zhang, HongJu
    Kukin, Marrick
    HEART FAILURE REVIEWS, 2018, 23 (03) : 355 - 361
  • [4] DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control
    Eun Ju Bae
    Archives of Pharmacal Research, 2016, 39 : 1114 - 1128
  • [5] DPP-4 Inhibitors and the Occurrence of Infections
    Willemen, M. J. C.
    Mantel-Teeuwisse, A. K.
    Straus, S. M. J. M.
    Egberts, A. C. G.
    Leufkens, H. G. M.
    DRUG SAFETY, 2010, 33 (10) : 937 - 937
  • [6] DPP-4 inhibitors and atherosclerosis: The promise
    Jialal, Ishwarlal
    Bajaj, Mandeep
    ATHEROSCLEROSIS, 2013, 227 (02) : 224 - 225
  • [8] Pharmacoeconomic analysis of DPP-4 inhibitors
    Teramachi, H.
    Ohta, H.
    Tachi, T.
    Toyoshima, M.
    Mizui, T.
    Goto, C.
    Tsuchiya, T.
    PHARMAZIE, 2013, 68 (11): : 909 - 915
  • [9] Renoprotective Effects of DPP-4 Inhibitors
    Kawanami, Daiji
    Takashi, Yuichi
    Takahashi, Hiroyuki
    Motonaga, Ryoko
    Tanabe, Makito
    ANTIOXIDANTS, 2021, 10 (02) : 1 - 17
  • [10] DPP-4 inhibitors: focus on safety
    Tella, Sri Harsha
    Rendell, Marc S.
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 127 - 140